0001209191-22-043762.txt : 20220801
0001209191-22-043762.hdr.sgml : 20220801
20220801191749
ACCESSION NUMBER: 0001209191-22-043762
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220527
FILED AS OF DATE: 20220801
DATE AS OF CHANGE: 20220801
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Christopher M
CENTRAL INDEX KEY: 0001436707
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41409
FILM NUMBER: 221126363
MAIL ADDRESS:
STREET 1: 125 CONSTITUTION DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QuidelOrtho Corp
CENTRAL INDEX KEY: 0001906324
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 874496285
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9975 SUMMERS RIDGE ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 552-1100
MAIL ADDRESS:
STREET 1: 9975 SUMMERS RIDGE ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: Coronado Topco, Inc.
DATE OF NAME CHANGE: 20220124
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2022-05-27
2022-06-01
0
0001906324
QuidelOrtho Corp
QDEL
0001436707
Smith Christopher M
9975 SUMMERS RIDGE ROAD
SAN DIEGO
CA
92121
1
0
0
0
Common Stock
2022-05-27
4
A
0
34554
A
34554
D
The Form 4 originally filed on June 1, 2022 is being amended to correct the vesting schedule with respect to 29,418 restricted stock awards held by the reporting person.
Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation, Ortho Clinical Diagnostics Holdings plc ("Ortho"), QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc., and Orca Holdco 2, Inc., each ordinary share of Ortho beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for (i) 0.1055 shares of common stock of QuidelOrtho and (ii) $7.14 in cash.
Includes 29,418 restricted stock awards, of which 4,203 shares vested on July 28, 2022, 16,811 shares will vest on September 9, 2022, 4,201 shares will vest on February 28, 2023 and 4,203 shares will vest on May 27, 2023.
/s/ Phillip S. Askim, attorney-in-fact for Christopher M. Smith
2022-08-01